Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-039329

Options or other derivatives

  • Director acquired 2,385 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ferrante Karen Jean Director 2021-10-01 Grant or award · Stock Option (Right to Buy) +2,385 $5.03 $12,001 2,385 D: show line 1 in the form
Loading xslF345X03/doc4.xml…